AVROBIO, Inc.
NASDAQ:AVRO
1.4 (USD) • At close June 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0.617 | 4.166 | 1.399 | 1.207 | 0.85 | 0 | 0 | 0 |
| Gross Profit
| -0.617 | -4.166 | -1.399 | -1.207 | -0.85 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 47.083 | 72.186 | 83.114 | 87.236 | 54.974 | 35.095 | 15.191 | 2.663 |
| General & Administrative Expenses
| 22.688 | 33.248 | 35.727 | 32.992 | 20.835 | 11.148 | 3.195 | 1.962 |
| Selling & Marketing Expenses
| 23.944 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 23.967 | 33.248 | 35.727 | 32.992 | 20.835 | 11.148 | 3.195 | 1.962 |
| Other Expenses
| 0 | -0.456 | -0.285 | 0.516 | 2.844 | -0.118 | -0.019 | -0.006 |
| Operating Expenses
| 71.05 | 105.434 | 118.841 | 120.228 | 75.809 | 46.243 | 18.386 | 4.625 |
| Operating Income
| -71.667 | -105.434 | -118.841 | -120.228 | -75.809 | -46.243 | -18.386 | -4.625 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 84.201 | -0.456 | -0.285 | 0.516 | 2.844 | -0.118 | -0.319 | -0.045 |
| Income Before Tax
| 12.534 | -105.89 | -119.126 | -119.712 | -72.965 | -46.361 | -18.648 | -4.664 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.377 | 0.157 | -1.399 | -1.207 | -0.85 | -0.118 | 0.243 | -0.006 |
| Net Income
| 12.157 | -106.047 | -117.727 | -118.505 | -72.115 | -46.361 | -18.648 | -4.664 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| 0.27 | -2.42 | -2.75 | -3.27 | -2.63 | -3.45 | -1.15 | -0.67 |
| EPS Diluted
| 0.27 | -2.42 | -2.75 | -3.27 | -2.63 | -3.45 | -1.15 | -0.67 |
| EBITDA
| -71.05 | -105.434 | -118.841 | -120.228 | -75.809 | -46.243 | -18.041 | -4.586 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |